Markt geschlossen -
Andere Börsenplätze
|
Vorbörslich 08:30:23 | |||
152.4 EUR | -0.85% | 152.5 | +0.11% |
05:52 | Scholz besucht Merck und Familienunternehmer-Tage | DP |
24.04. | Deutsche Pharmabranche erwartet wieder Wachstum - hoher Krankenstand hilft | AW |
Kurzporträt
- Lösungen und Produkte für die wissenschaftliche und biotechnologische Forschung (44,2%);
- Pharmaprodukte (38,4%): verschreibungspflichtige Medikamente zur Behandlung von Diabetes, Diabetes, Krebs, Multipler Sklerose, Unfruchtbarkeit, Herz-Kreislauf-Erkrankungen, Erkrankungen des Zentralnervensystems, Entzündungskrankheiten usw.;
- Performance-Materialien für die Elektronikindustrie (17,4%): Halbleitermaterialien, Flüssigkristalle, Pigmente und Additive, organische Materialien auf Kohlenstoffbasis, usw.
Die geografische Verteilung des Umsatzes sieht aus wie folgt: Deutschland (4,8%), Europa (24%), China (12,9%), Asien / Pazifik (20,1%), USA (26,8%), Nordamerika (1,6%), Lateinamerika (6,3%), Mittlerer Osten und Afrika (3,5%).
Mitarbeiterzahl: 62 908
Umsatz nach Geschäftsbereich
EUR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Life Science
44,2
%
| 10 380 | 46,7 % | 9 281 | 44,2 % | -10.59% |
Healthcare
38,4
%
| 7 839 | 35,3 % | 8 053 | 38,4 % | +2.73% |
Electronics
17,4
%
| 4 013 | 18,1 % | 3 659 | 17,4 % | -8.82% |
Umsatz je Region
EUR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
28,2
%
| 6 302 | 28,3 % | 5 911 | 28,2 % | -6.20% |
Europe
21,0
%
| 4 524 | 20,3 % | 4 402 | 21,0 % | -2.70% |
Asia Pacific
19,9
%
| 4 479 | 20,1 % | 4 181 | 19,9 % | -6.65% |
China
11,8
%
| 2 818 | 12,7 % | 2 477 | 11,8 % | -12.10% |
Germany
6,8
%
| 1 532 | 6,9 % | 1 420 | 6,8 % | -7.31% |
Latin America
6,0
%
| 1 175 | 5,3 % | 1 267 | 6,0 % | +7.83% |
Middle East and Africa
2,5
%
| 516 | 2,3 % | 535 | 2,5 % | +3.68% |
Switzerland
2,4
%
| 592 | 2,7 % | 512 | 2,4 % | -13.51% |
North America
1,4
%
| 294 | 1,3 % | 287 | 1,4 % | -2.38% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 62 | 13.07.20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01.08.14 |
Director of Finance/CFO | 53 | 26.04.19 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.19 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01.11.20 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
Corporate Officer/Principal | - | 01.09.21 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01.01.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01.05.12 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01.01.91 |
Dietmar Oeter
BRD | Director/Board Member | 57 | 01.01.95 |
Alexander Putz
BRD | Director/Board Member | 47 | 01.01.85 |
Director of Finance/CFO | 53 | 26.04.19 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 11.08.23 |
Sascha Held
BRD | Director/Board Member | - | 26.04.19 |
Anne Lange
BRD | Director/Board Member | - | 26.04.19 |
Daniel Thelen
BRD | Director/Board Member | - | 26.04.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 305 535 626 | 0 | 0 | 29,71 % |
Aktie B | 1 | 129 242 252 | 129 159 619 ( 99,94 %) | 0 |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
2 787 509 | 4,65% | 140 016 577 $ | |
PT MERCK TBK 86,65% | 388 194 920 | 86,65% | 97 693 134 $ |
VERA THERAPEUTICS, INC. 3,48% | 1 913 501 | 3,48% | 82 510 163 $ |
PRECIGEN, INC. 8,29% | 20 647 152 | 8,29% | 29 938 370 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. |
Miscellaneous Commercial Services
|
Pharmaceuticals: Major
| |
Ares Trading SA
| |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
AZ Electronic Materials (Japan) KK
AZ Electronic Materials (Japan) KK Chemicals: SpecialtyProcess Industries AZ Electronic Materials (Japan) KK manufactures plastic materials and inorganic chemicals. The company is located in Tokyo, Japan |
Chemicals: Specialty
|
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Merck Financial Services GmbH
Merck Financial Services GmbH Finance/Rental/LeasingFinance Part of Merck KGaA, Merck Financial Services GmbH provides financing operations and activities. The private company is based in Darmstadt, Germany. The CEOs are Jörg Bermüller, Rando Bruns. The German company was founded in 2007. |
Finance/Rental/Leasing
|
Millipore SAS
Millipore SAS Electronic Equipment/InstrumentsElectronic Technology Founded in 1972, Millipore SAS is a subsidiary of Merck KGaA that provides industrial instruments for measurement. The private company is based in Molsheim, France. |
Electronic Equipment/Instruments
|
Merck Life Science A/S
Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The private company is located in Denmark. |
Electronic Equipment/Instruments
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+5.73% | 70.78 Mrd. | |
+10.72% | 9.15 Mrd. | |
-15.34% | 4.84 Mrd. | |
+34.54% | 4.22 Mrd. | |
+5.09% | 3.92 Mrd. | |
+27.76% | 2.55 Mrd. | |
-28.33% | 2.24 Mrd. | |
-24.15% | 2.26 Mrd. | |
+6.23% | 1.92 Mrd. | |
-0.50% | 1.64 Mrd. |
- Börse
- Aktien
- 659990 Aktie
- Unternehmen Merck KGaA